|
National Stock Number(NSN): 6505-01-025-8576 (6505010258576, 010258576)
| NIIN: |
01-025-8576 |
Item Name: |
CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE CAPSULES |
INC: |
26678
|
| FSC: |
6505
|
Assignment Date: |
Aug-11-1976 |
CRIT: |
X |
IIG: |
26678 |
| ISC: |
5 |
Date Standardized: |
Aug-11-1976 |
HMIC: |
P |
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Aug-31-2022 |
PMIC: |
A |
FIIG: |
A510U0 |
| ESD: |
|
Schedule B: |
3004.90.9235 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
NDC00140-0007-51 |
04493
|
HOFFMANN-LA ROCHE INC. |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
|
NDC00879-0501-23 |
60964
|
HALSEY DRUG CO INC |
H |
3 |
2 |
6 |
54 |
|
|
|
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
5.000 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT |
| AKJC |
CAPSULE TYPE |
ANY ACCEPTABLE |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE |
| CQLS |
CAPSULE CONTENT FORM |
POWDER |
| CYLZ |
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY |
120.000 |
| FEAT |
SPECIAL FEATURES |
ACTIVE MEDICAMENT MEDICINAL STRENGTH:5.000 MILLIGRAMS OF CHLORDIAZEPOXIDE ACTIVE INGREDIENTS |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| G57V |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54|57 |
|